Infectious Diseases
At iNGENū CRO, our team brings extensive expertise in infectious disease research, offering high-quality, flexible, and accelerated solutions tailored to meet the dynamic needs of global sponsors.
Conducting clinical trials in infectious diseases requires an in-depth understanding of rapidly evolving pathogens, complex patient management, strict infection control measures, and the ability to respond swiftly to emerging threats. We collaborate closely with infectious disease specialists and maintain strong partnerships with clinical sites globally to ensure rapid mobilisation and execution of trials.
Our clinical team has substantial experience across a broad spectrum of infectious conditions, including:
- Viral Infections (COVID-19, Hepatitis B & C, HIV)
- Bacterial Infections (Tuberculosis, MRSA)
- Fungal Infections (Candidiasis, Aspergillosis)
- Parasitic Diseases (Malaria, Leishmaniasis)
- Vaccine Development and Evaluation
- Antimicrobial Resistance
Disciplined,
Cost-Efficient Execution
while maintaining the Highest Quality
Local Trials,
Global Approvals
Access FDA Regulatory Expertise
Our Clinical Team has over
120
years
of Combined Clinical Trial Experience
Infectious Diseases Clinical Trial Resources
HIV/AIDS
Navigating the Complexities of HIV/AIDS Clinical Trials. Explore diagnostic criteria, pivotal endpoints, and regulatory pathways.
Addressing Common Pain Points Associated with Infectious Disease Clinical Trials
Biosafety and Infection Control
Problem:
Clinical trials in infectious diseases necessitate stringent biosafety measures to protect patients, staff, and communities.
iNGENū CRO addresses this pain point with Rigorous Biosafety Protocols:
Our team implements comprehensive infection control protocols aligned with global biosafety standards. We provide thorough training and continuous monitoring across all sites, ensuring the highest safety measures are consistently maintained throughout the trial.
Dynamic Regulatory Environment
Problem:
Regulatory landscapes can rapidly change during infectious disease outbreaks, complicating trial design and execution.
iNGENū CRO addresses this pain point with Expert Regulatory Navigation:
Our regulatory experts possess deep knowledge of global and regional requirements for infectious disease trials. We provide agile and proactive regulatory support, ensuring compliance and facilitating timely approvals even amidst rapidly changing guidelines.
Complexity of Outcome Measures
Problem:
Infectious diseases often involve multifaceted outcome measures, including viral load, immune response, and clinical endpoints, complicating data collection and analysis.
iNGENū CRO addresses this pain point with Comprehensive Outcome Assessment:
We integrate robust methodologies for both clinical and laboratory outcome assessments. Our experienced clinical team and centralised laboratories ensure standardised, accurate, and timely data collection and analysis, simplifying complex trial outcomes.
Rapid Patient Recruitment and Site Activation
Problem:
Infectious disease outbreaks often require rapid response times, making swift patient recruitment and site activation critical.
iNGENū CRO addresses this pain point with Accelerated Recruitment and Activation:
We maintain a global network of pre-qualified clinical sites with rapid start-up capabilities. Our advanced patient databases and strategic partnerships with infectious disease centres enable us to identify and enroll eligible patients quickly, ensuring timely trial initiation.
Safety and Adverse Event Management
Problem:
Trials involving novel therapies or vaccines for infectious diseases carry inherent safety risks that require vigilant monitoring and rapid response capabilities.
iNGENū CRO addresses this pain point with Enhanced Safety Monitoring:
We employ advanced safety monitoring systems and real-time data analytics. Our dedicated safety board proactively reviews data to swiftly identify and manage potential adverse events, ensuring participant safety and maintaining trial integrity.
The iNGENū CRO Difference
Local Trials, Global Approvals
We uniquely combine Australian expertise with direct FDA submission capabilities.
Disciplined, Cost-Efficient Execution
iNGENū CRO takes a highly strategic approach to clinical research.
Australian-Headquartered, Asia-Pacific Reach
We provide sponsors with comprehensive trial capabilities.
We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have been very happy with all aspects of the management of the clinical trial.
Ready to discuss your Infectious Diseases Clinical Trial?